The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Open accessAbstract
Because melanogenesis can affect immune responses to and chemotherapy and radiotherapy for melanoma, we analyzed overall survival and disease-free survival times in melanoma patients in relation to the degree of tumor pigmentation. Clinicopathologic data were obtained from the Oncology Centre, Prof Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. The overall survival and disease-free survival analyses were performed using the log-rank test, whereas differences between mean/median overall survival and disease-free survival (days) were analyzed using the Student t test. In patients with metastatic disease, those with melanotic melanomas exhibited significantly shorter disease-free survival and overall survival than those with amelanotic lesions. Similarly, melanin-producing lymph node metastases were linked to shorter overall survival and disease-free survival, which was confirmed by a significantly longer mean/median disease-free survival for amelanotic versus melanotic metastases. Melanogenesis shortens overall survival and disease-free survival in patients with metastatic melanoma. Inhibition of melanogenesis appears a rational adjuvant approach to the therapy of metastatic melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of the VDR and CYP27B1 decreased during melanoma progression, and melanization and melanogenesis negatively affected both overall- and stage III disease-survival”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hauschild, A., Grob, J., Демидов, Л. В., Jouary, T., Gutzmer, R., Millward, M. J., Rutkowski, P. L., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 3,050
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Self-citationMitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., Guerrero, C. R., Lennerz, J. K., Mihm, M. C., Wargo, J. A., et al. (2012) · Nature · doi:10.1038/nature11624 · Cited by 497
L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions
Slominski, A. T., Zmijewski, M. A., & Pawelek, J. M. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00898.x · Cited by 449
Self-citationSlominski, A. T., Zbytek, B., & Slominski, R. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24005 · Cited by 203
Self-citationMelanoma: New Insights and New Therapies
Nikolaou, V. A., Stratigos, A., Flaherty, K. T., & Tsao, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.421 · Cited by 164
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
Brożyna, A. A., VanMiddlesworth, L., & Slominski, A. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23664 · Cited by 137
Self-citationExpression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
Self-citationSlominski, A. T., Paus, R., & Mihm, M. C. (1999) · PubMed · Cited by 109
Self-citationGidanian, S., Mentelle, M., Meyskens, F. L., & Farmer, P. J. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00309.x · Cited by 63
Cited by
Sorted by citations
Signaling Pathways in Melanogenesis
D’mello, S. A. N., Finlay, G. J., Baguley, B. C., & Askarian-Amiri, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071144 · Cited by 1,134
Biological Activities of Stilbenoids
Akinwumi, B. C., Bordun, K.-A., & Anderson, H. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030792 · Cited by 392
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship
Slominski, R. M., Sarna, T., Plonka, P. M., Raman, C., Brożyna, A. A., & Slominski, A. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842496 · Cited by 310
Self-citationTargeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 284
Melanin content in melanoma metastases affects the outcome of radiotherapy
Brożyna, A. A., Jóźwicki, W., Roszkowski, K., Filipiak, J., & Slominski, A. T. (2016) · Oncotarget · doi:10.18632/oncotarget.7528 · Cited by 209
Self-citationThe role of melanin pigment in melanoma
Slominski, R. M., Zmijewski, M. A., & Slominski, A. T. (2014) · Experimental Dermatology · doi:10.1111/exd.12618 · Cited by 207
Self-citationObaid, R. J., Mughal, E. U., Naeem, N., Sadiq, A., Alsantali, R. I., Jassas, R. S., Moussa, Z., & Ahmed, S. A. (2021) · RSC Advances · doi:10.1039/d1ra03196a · Cited by 200
Slominski, A. T., Kim, T.-K., Li, W., Yi, A.-K., Postlethwaite, A., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.012 · Cited by 170
Self-citationRoulier, B., Pérès, B., & Haudecoeur, R. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00994 · Cited by 149
The metabolism of melanin synthesis—From melanocytes to melanoma
Snyman, M., Walsdorf, R. E., Wix, S., & Gill, J. G. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13165 · Cited by 157
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citationMelanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
Slominski, A. T., & Carlson, J. A. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.02.009 · Cited by 129
Self-citationLim, H. N., Baek, S. B., & Jung, H. J. (2019) · Molecules · doi:10.3390/molecules24050929 · Cited by 112
Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis
Xie, R., Li, B., Jia, L., & Li, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020794 · Cited by 107
Rose, A. A. N., Biondini, M., Curiel, R. E., & Siegel, P. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.010 · Cited by 103
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance
Gelmi, M. C., Houtzagers, L. E., Strub, T., Krossa, I., & Jager, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116001 · Cited by 115
Salmi, S., Siiskonen, H., Sironen, R. K., Tyynelä-Korhonen, K., Hirschovits-Gerz, B., Valkonen, M., Auvinen, P., & Pasonen‐Seppänen, S. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000522 · Cited by 90
Quantitative analysis of melanin content in a three-dimensional melanoma cell culture
Chung, S., Lim, G. J., & Lee, J. Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37055-y · Cited by 91
Brożyna, A. A., Jóźwicki, W., & Slominski, A. T. (2014) · PubMed · Cited by 87
Self-citationLogesh, R., Prasad, S. R., Chipurupalli, S., Robinson, N., & Mohankumar, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188968 · Cited by 92
Current Molecular Markers of Melanoma and Treatment Targets
Yang, K., Oak, A. S. W., Slominski, R. M., Brożyna, A. A., & Slominski, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103535 · Cited by 80
Self-citationMalignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Slominski, R. M., Kim, T., Janjetović, Z., Brożyna, A. A., Podgórska, E., Dixon, K. M., Mason, R. S., Tuckey, R. C., Sharma, R., Crossman, D. K., et al. (2024) · Cancers · doi:10.3390/cancers16122262 · Cited by 79
Self-citationRORα and RORγ expression inversely correlates with human melanoma progression
Brożyna, A. A., Jóźwicki, W., Skobowiat, C., Jetten, A. M., & Slominski, A. T. (2016) · Oncotarget · doi:10.18632/oncotarget.11211 · Cited by 70
Self-citationResveratrol as a Multifunctional Topical Hypopigmenting Agent
Na, J., Shin, J. W., Choi, H.-R., Kwon, S., & Park, K.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040956 · Cited by 70
Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells
Sarna, M., Żądło, A. C., Hermanowicz, P., Madeja, Z., Burda, K., & Sarna, T. (2014) · Experimental Dermatology · doi:10.1111/exd.12535 · Cited by 63
de Assis, L. V. M., Moraes, M. N., Magalhães-Marques, K. K., & Castrucci, A. M. D. L. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.01.004 · Cited by 65
Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances
Kim, H. J., & Kim, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052984 · Cited by 69
Vitamin D Deficiency at Melanoma Diagnosis Is Associated with Higher Breslow Thickness
Wyatt, C., Lucas, R. M., Hurst, C. P., & Kimlin, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126394 · Cited by 63
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors
Haudecoeur, R., Carotti, M., Gouron, A., Maresca, M., Buitrago, E., Hardré, R., Bergantino, E., Jamet, H., Belle, C., Réglier, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00369 · Cited by 61
The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
Cabaço, L. C., Tomás, A., Pojo, M., & Barral, D. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887366 · Cited by 60
Chae, J. K., Subedi, L., Jeong, M., Park, Y. I., Kim, C. Y., Kim, H., & Kim, S. Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020471 · Cited by 54
Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma
Okamoto, H., Yoshimatsu, Y., Tomizawa, T., Kunita, A., Takayama, R., Morikawa, T., Komura, D., Takahashi, K., Oshima, T., Sato, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39018-3 · Cited by 54
Babapoor, S., Fleming, E. S., Wu, R., & Dadras, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107502 · Cited by 53
Wang, L., Li, Y., & Chen, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190447 · Cited by 51
MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB
Rose, A. A. N., Annis, M. G., Frederick, D. T., Biondini, M., Dong, Z., Kwong, L. N., Chin, L., Keler, T., Hawthorne, T. R., Watson, I. R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1192 · Cited by 53
Tichá, I., Hojny, J., Michálková, R., Kodet, O., Krkavcová, E., Hájková, N., Němejcová, K., Bártů, M., Jakša, R., Důra, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53636-x · Cited by 52
Wasiewicz, T., Szyszka, P., Cichorek, M., Janjetović, Z., Tuckey, R. C., Slominski, A. T., & Zmijewski, M. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16046645 · Cited by 49
Self-citationDevelopment and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
Valpione, S., Moser, J. C., Parrozzani, R., Bazzi, M., Mansfield, A. S., D, S. M. M., Pigozzo, J., Midena, E., Markovic, S. N., Aliberti, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120181 · Cited by 49
de Lange, M. J., Razzaq, L., Versluis, M., Verlinde, S., Doğrusöz, M., Böhringer, S., Marinkovic, M., Luyten, G. P. M., de Keizer, R. J. W., de Gruijl, F. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138002 · Cited by 48
Roulier, B., Rush, I., Lazinski, L. M., Pérès, B., Olleik, H., Royal, G., Fishman, A., Maresca, M., & Haudecoeur, R. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114972 · Cited by 47
The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
Barbai, T., Fejôs, Z., Puskás, L. G., Tı́már, J., & Rásó, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5059 · Cited by 47
Kudo, M., Kobayashi, K., & Tsuji, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171513 · Cited by 48
CYP24A1 Expression Inversely Correlates with Melanoma Progression: Clinic-Pathological Studies
Brożyna, A. A., Jochymski, C., Janjetović, Z., Jóźwicki, W., Tuckey, R. C., & Slominski, A. T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151019000 · Cited by 44
Self-citationBeauvericin inhibits melanogenesis by regulating cAMP/PKA/CREB and LXR-α/p38 MAPK–mediated pathways
Lee, S. E., Park, S., Oh, S. W., Yoo, J. A., Kwon, K., Park, S. J., Kim, J., Lee, H. S., Cho, J. Y., & Lee, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33352-8 · Cited by 42
Rather, R. A., Bhagat, M., & Singh, S. K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108321 · Cited by 43
P-Selectin-Mediated Platelet Adhesion Promotes the Metastasis of Murine Melanoma Cells
Qi, C., Wei, B., Ye, J., Yang, Y., Li, B., Zhang, Q., Li, J., He, X., Lan, T., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091320 · Cited by 41
Śniegocka, M., Podgórska, E., Plonka, P. M., Elas, M., Romanowska‐Dixon, B., Szczygieł, M., Zmijewski, M. A., Cichorek, M., Markiewicz, A., Brożyna, A. A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041048 · Cited by 41
Self-citationde Assis, L. V. M., Moraes, M. N., Magalhães-Marques, K. K., Kinker, G. S., Cruz‐Machado, S. D. S., & Castrucci, A. M. D. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041065 · Cited by 42
Ma, X., Wang, S., Wang, S., Liu, D., Zhao, X., Chen, H., Kang, F., Yang, W., Wang, J., & Cheng, Z. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209643 · Cited by 41
Fusion of bone marrow-derived cells with cancer cells: metastasis as a secondary disease in cancer
Pawelek, J. M. (2014) · 癌症：英文版 · doi:10.5732/cjc.013.10243 · Cited by 41
Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3
Buart, S., Terry, S., Noman, M. Z., Lanoy, É., Boutros, C., Fogel, P., Dessen, P., Meurice, G., Gaston‐Mathé, Y., Vielh, P. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22150 · Cited by 39
Clinical Characteristics of 582 Patients with Uveal Melanoma in China
Liu, Y. M., Li, Y., Wei, W. B., Xu, X., & Jonas, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144562 · Cited by 38
PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis
Lin, Z., Chen, X., Li, Z., Luo, Y., Fang, Z., Xu, B., & Han, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160485 · Cited by 38
Markiewicz, A., Brożyna, A. A., Podgórska, E., Elas, M., Urbańska, K., Jetten, A. M., Slominski, A. T., Jóźwicki, W., Orłowska-Heitzman, J., Dyduch, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45161-8 · Cited by 38
Self-citationPawlikowska, M., Piotrowski, J., Jędrzejewski, T., Kozak, W., Slominski, A. T., & Brożyna, A. A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6513 · Cited by 36
Self-citationWolf, J., Auw‐Haedrich, C., Schlecht, A., Boneva, S., Mittelviefhaus, H., Lapp, T., Agostini, H. T., Reinhard, T., Schlunck, G., & Lange, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-72864-0 · Cited by 36
Han, D., Wang, S., Hu, Y., Zhang, Y., Dong, X., Yang, Z., Wang, J., Li, J., & Deng, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125686 · Cited by 35
Tam, I., Dzierżęga‐Lęcznar, A., & Stȩpień, K. B. (2019) · Experimental Dermatology · doi:10.1111/exd.13908 · Cited by 34
Rafiq, M., Nazir, Y., Ashraf, Z., Rafique, H., Afzal, S., Mumtaz, A., Hassan, M., Ali, A., Afzal, K., Yousuf, M. R., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1654468 · Cited by 33
MC1R and melanin-based molecular probes for theranostic of melanoma and beyond
Shi, H., & Cheng, Z. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00970-y · Cited by 33
The Development of Sugar-Based Anti-Melanogenic Agents
Bin, B.-H., Kim, S. S., Bhin, J., Lee, T. H., & Cho, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040583 · Cited by 33
Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation
Ni, X., Luo, X., Jiang, X., Chen, W., & Bai, R. (2025) · Molecules · doi:10.3390/molecules30040788 · Cited by 32
Rouanet, J., Quintana, M., Auzeloux, P., Cachin, F., & Degoul, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107829 · Cited by 32
Wróblewska, J. P., Mull, J., Wu, C.-L., Fujimoto, M., Ogawa, T., Marszałek, A., & Hoang, M. P. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001166 · Cited by 31
Czyż, M., Sztiller-Sikorska, M., Gajos-Michniewicz, A., Osrodek, M., & Hartman, M. L. (2019) · Journal of Oncology · doi:10.1155/2019/1697913 · Cited by 31
Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells
Wolnicka-Głubisz, A., Nogal, K., Żądło, A. C., & Plonka, P. M. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1523-1 · Cited by 30
Lee, W., Shen, S., Wu, P., Chou, C., Shih, Y., Yeh, C., Yeh, K., & Jiang, M. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22407 · Cited by 31
Nosanchuk, J. D., Jeyakumar, A., Ray, A., Revskaya, E., Jiang, Z., Bryan, R. A., Allen, K. J. H., Jiao, R., Malo, M. E., Gómez, B. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23889-z · Cited by 30
Stage-specific prognostic biomarkers in melanoma
Cheng, Y., Lü, J., Chen, G., Ardekani, G. S., Rotte, A., Martinka, M., Xu, X., McElwee, K. J., Zhang, G., & Zhou, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.2907 · Cited by 29
Tudor, D. V., Nenu, I., Filip, G. A., Olteanu, D. E., Cenariu, M., Tăbăran, F., Ion, R. M., Gligor, L., & Bâldea, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173241 · Cited by 29
Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
Casalou, C., Moreiras, H., Mayatra, J. M., Fabre, A., & Tobin, D. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.878336 · Cited by 28
Wang, S., Fan, W., Wan, B., Tu, M., Jin, F., Liu, F., Xu, H., & Han, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172498 · Cited by 27
Becker, A. L., Carpenter, E. L., Slominski, A. T., & Indra, A. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.743667 · Cited by 27
Self-citationKosiniak-Kamysz, A., Marczakiewicz-Lustig, A., Marcińska, M., Skowron, M., Wojas‐Pelc, A., Pośpiech, E., & Branicki, W. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000095 · Cited by 25
Grabacka, M., Wieczorek, J., Michalczyk‐Wetula, D., Malinowski, M., Wolan, N., Wojcik, K., & Plonka, P. M. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-016-1711-2 · Cited by 25
Xu, H., Gong, J., & Liu, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189675 · Cited by 25
Brożyna, A. A., Jóźwicki, W., Jetten, A. M., & Slominski, A. T. (2019) · Experimental Dermatology · doi:10.1111/exd.14002 · Cited by 25
Self-citationYu, J., Luo, X. G., Huang, H., Zhai, Z., Shen, Z., & Lin, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165591 · Cited by 25
Konstantakou, E. G., Velentzas, A. D., Anagnostopoulos, A. K., Litou, Z. I., Konstandi, O. A., Giannopoulou, A. F., Anastasiadou, E., Voutsinas, G. E., Tsangaris, G. T., & Stravopodis, D. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171512 · Cited by 26
Novak, M., Leonard, M. K., Yang, X. H., Kowluru, A., Belkin, A. M., & Kaetzel, D. M. (2015) · Experimental Dermatology · doi:10.1111/exd.12697 · Cited by 24
Rossi, A. H., Farias, A. R., Fernández, J. E., Bonomi, H. R., Goldbaum, F. A., & Berguer, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126827 · Cited by 27
New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma
Militaru, I. V., Rus, A. A., Munteanu, C. V. A., Manica, G., & Petrescu, S. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1061832 · Cited by 23
Chai, W., Wang, R., Wei, M.-K., Zou, Z.-R., Deng, R.-G., Liu, W., & Peng, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145483 · Cited by 23
Melanoma—Time to fast or time to feast? An interplay between PPARs, metabolism and immunity
Grabacka, M., Plonka, P. M., & Reiss, K. (2020) · Experimental Dermatology · doi:10.1111/exd.14072 · Cited by 22
Mohapatra, D., Kumar, D. N., Shreya, S., Pandey, V., Dubey, P. K., Agrawal, A. K., & Sahu, A. N. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01375-y · Cited by 22
Viallard, C., Perrot, Y., Boudhraa, Z., Jouberton, E., Miot-Noirault, E., Bonnet, M., Besse, S., Mishellany, F., Cayre, A., Maigne, L., et al. (2015) · European Journal of Dermatology · doi:10.1684/ejd.2014.2481 · Cited by 22
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification
Parikh, R., Parikh, S., Berzin, D., Vaknine, H., Ovadia, S., Likonen, D., Greenberger, S., Scope, A., Elgavish, S., Nevo, Y., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00103-7 · Cited by 21
Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration
Onken, M. D., Li, J., & Cooper, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115472 · Cited by 21
Melanopsin (Opn4) is an oncogene in cutaneous melanoma
de Assis, L. V. M., Lacerda, J. T., Moraes, M. N., Domínguez-Amorocho, O. A., Kinker, G. S., Mendes, D., Silva, M. M., Menck, C. F. M., Câmara, N. O. S., & Castrucci, A. M. D. L. (2022) · Communications Biology · doi:10.1038/s42003-022-03425-6 · Cited by 21
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
Vercellino, L., de Jong, D., Dercle, L., Hosten, B., Braumuller, B., Das, J. P., Deng, A., Moya‐Plana, A., A’Keen, C. V., Yeh, R., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051116 · Cited by 20
Coricovac, D. E., Watz, C. G., Nica, C., Pînzaru, I., Simu, S., Stoian, D. L., Şoica, C., Proks, M., Avram, Ș., Navolan, D. B., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113600 · Cited by 20
Huang, H., Fu, Z., Jiang, J., Huang, J., & Xiao, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817510 · Cited by 19
Wang, X., Chen, Y., Lan, B., Wang, Y., Lin, W., Jiang, X., Ye, J., Shang, B., Feng, C., Liu, J., et al. (2022) · Theranostics · doi:10.7150/thno.69198 · Cited by 19
Gelmi, M. C., Wierenga, A. P. A., Kroes, W. G. M., van Duinen, S. G., Karuntu, J. S., Marinkovic, M., Bleeker, J. C., Luyten, G. P. M., Vu, T. H. K., Verdijk, R. M., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100297 · Cited by 20
Seino, H., Arai, Y., Nagao, N., Ozawa, N., & Hamada, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164061 · Cited by 19
Liu, Y., Hao, Y., Li, Y., Zheng, Y., Dai, J., Zhong, F., Wei, W., & Fang, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-75598-1 · Cited by 18
Brożyna, A. A., Guo, H., Yang, S., Cornelius, L. A., Linette, G. P., Murphy, M. J., Sheehan, C., Ross, J. S., Slominski, A. T., & Carlson, J. A. (2016) · Journal of Cutaneous Pathology · doi:10.1111/cup.12872 · Cited by 17
Self-citationMohapatra, D., Kumar, D. N., Shreya, S., Panigrahi, D., Agrawal, A. K., & Sahu, A. N. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0069 · Cited by 15
Ren, H., Wang, G., Jiang, J., Li, J., Fu, L. N., Liu, L., Li, N., Zhao, J., Sun, X., Zhang, L., et al. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00072.2017 · Cited by 15
Whole Body Melanoma Transcriptome Response in Medaka
Schartl, M., Shen, Y., Maurus, K., Walter, R., Tomlinson, C., Wilson, R. K., Postlethwait, J. H., & Warren, W. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143057 · Cited by 17
Metadata
- Authors
- Brożyna, A. A., Jóźwicki, W., Carlson, J. A., & Slominski, A. T.
- Affiliations
- Nicolaus Copernicus University (PL)
- Albany Medical College (US)
- University of Tennessee Health Science Center (US)
- Corresponding author
- Slominski, Andrzej T.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 44
- Issue
- 10
- Pages
- 2071-2074
- ISSN
- 0046-8177 (ISSN-L)
- PMC
- PMC3783651
- OpenAlex
- W2062933772
- Cited by
- 175
- References
- 13
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 13 · 2023: 8 · 2022: 21 · 2021: 11 · 2020: 9 · 2019: 17 · 2018: 14 · 2017: 16 · 2016: 14 · 2015: 17 · 2014: 14 · 2013: 1
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Pathology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056666)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanogenesis, melanoma, tumor pigmentation, melanin, metastatic melanoma, lymph node metastasis, overall survival, disease-free survival, amelanotic melanoma, adjuvant therapy, melanogenesis inhibition
- MeSH terms
- Humans, Lymph Nodes, Lymphatic Metastasis, Melanoma, Melanosis, Neoplasm Staging, Poland, Skin Neoplasms, Comorbidity, Survival Rate, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
